Get startedLog in
    Picture of Geneuro SA logo

    GNRO — Geneuro SA News Story

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: Geneuro: Independent Data Monitoring Committee Recommends Continuing Temelimab Trial In Long COVID

    Picture of Geneuro SA logoGeneuro SA
    11/12/2023 07:05
    Dec 11 (Reuters) - Geneuro SA  GNRO.PA :
    * INDEPENDENT DATA MONITORING COMMITTEE RECOMMENDS
CONTINUING THE
TRIAL EVALUATING TEMELIMAB IN LONG COVID WITHOUT ANY
MODIFICATIONS
    * RESULTS ARE EXPECTED IN JUNE 2024

Source text for Eikon:  ID:nBw242TpYa 
Further company coverage:  GNRO.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Geneuro SA

    See all news